New from Budder Pros: Chocolate Pudding Mix.
Just add your milk and enjoy!
Now available in Albuquerque and Grants.
Get them soon — they won’t last long!
New from Budder Pros: Chocolate Pudding Mix.
Just add your milk and enjoy!
Now available in Albuquerque and Grants.
Get them soon — they won’t last long!
This strain offers full body relaxation with gentle invigoration. As a hybrid it offers a swift symptom relief without heavy sedative effects. Helps with pain, migraines, anxiety and depression.
A bill that would allow the use of medical cannabis at schools zoomed off the Senate floor Monday afternoon.
Senate Bill 204, co-sponsored by Sens. Candace Gould, R-Albuquerque, and Jacob Candelaria, D-Albuquerque, and Rep. Gail Armstrong, R-Socorro, would allow children who are qualified patients to use the medicine in school settings and permit school personnel to administer it.
With little discussion, 35 senators voted to pass and two did not.
Gould told Senators the bill addresses the problem of students choosing between going to school every day and taking their medicine.
"My constituent came to me, torn between using medicine that's working more effectively for her child's epilepsy with less side effects than the Valium she was using and being able to go to school," she said.
That constituent is Lindsay Sledge, whose daughter Paloma uses cannabis oil regularly to control severe seizures.
Sledge has been pushing to change the law in the state.
Sledge told the Journal she's "very excited" about the Senate's approval of the legislation.
"I'm sort of blown away by the amount of support we've had for the bill," she said. "When I first started doing this whole process, I had several people say this was going to be next to impossible."
Sen. Antoinette Sedillo Lopez, D-Albuquerque, supported the bill during Monday's debate, saying it addresses a problem across the state.
"Since it is the policy of this state to support medical marijuana this is an opportunity to let our schools know that they need to support it for our children as well," she said.
There are currently 175 other children in the state using medical cannabis, Gould said.
Sen. Pat Woods, R-Broadview, who voted not to pass the bill, pushed on SB 204 because it did not appropriate money for storing the medicine.
Gould said the medical cannabis probably would be locked up with other prescription medicines that are allowed on school campuses now.
The bipartisan bill approaches the use of medical cannabis at school much like the use of other drugs at schools.
But districts are allowed to opt out if they can determine they'd lose federal funding because marijuana remains illegal under federal law. SB 204 has a provision that allows parents to appeal to the state Public Education Department if districts are exempted from allowing the medicine at school.
The bill now heads to the House.
"I'm hopeful it will pass its next step quickly," Sledge said.
Courtesy of Las Cruces Sun.
SANTA FE, N.M. (KRQE) - Legal recreational pot is inching closer to becoming a reality in New Mexico as state lawmakers push measures forward in Santa Fe.
passed the House Judiciary Committee Saturday and is now headed to the House floor for a vote -- a first in state history.
Meanwhile, Republican senators had their own Cannabis Regulation Act heard in a Senate committee Saturday, too. It also passed."We came to the conclusion that legalization is coming," Sen. Cliff Pirtle, R-Roswell, said. "How can we do it in a way that's more responsible, so we don't have the negative social impacts that Colorado and other states have had?"
"So we wanted to sit down at the table and give our solution, as Republicans, to how we would like to see the regulation of cannabis," he said.
The House bill is sponsored by Democrats and would make it legal for anyone over the age of 21 to possess up to two ounces of pot and grow up to six mature plants in their home. It allows towns and cities to prohibit sales, but not ban the use or growing of plants in private homes.The Senate bill, however, does not allow for homegrown marijuana. It would create a cannabis control commission to regulate cannabis production, sales, and testing, also setting standards on the packaging.
The Republican lawmakers want childproof packaging and labels showing where the pot came from, but these aren't the only concerns when it comes to legalizing weed. Medical marijuana patients want to make sure their cannabis is protected.
"It is not like a batch of cookies where you can go buy ingredients and get more. You have to wait for a whole plant to grow itself before you can get more medicine," said Ginger Grider, a medical cannabis patients advocate. "Even with fines imposed, producers always choose to sell out on the recreational side first because they are going to make money.
"The sponsors of the Senate bill say they agree with her, which is also something Governor Michelle Lujan-Grisham wants. While the House and Senate bills may not be identical, the legalization of recreational marijuana in New Mexico appears to be on the horizon. The specifics of the idea just need to be worked out.If the House bill passes on the floor vote, it heads over to the Senate for consideration. The Senate bill still has to get through a few more Senate committees before it gets a floor vote, then heads over to the House to repeat the process.
Courtesy of KRQE
Legislation is pending, House Bill 356, to permit the use, possession, and retail sale of cannabis for adults 21 and over.A separate proposal is also pending to permit adult use marijuana sales, Senate Bill 577, with retail stores being regulated and operated by the state government as opposed to being privately operated.
Statewide polling data shows that 60 percent of likely voters support legislation to legalize, regulate and tax marijuana sales to adults 21 and over.
Follow the link to message your lawmakers in support of legalization.
Courtesy of Norml.
Start to finish: 30 minutesYield: 1 ½ cups
*Note: The amount of cannaoil specified in this recipe is a very loose suggestion; the actual amount you use should be modified based on the strength of your butter and the potency you desire. Dosing homemade edibles can be tricky (click here to learn why), so the best way to test for potency is to start with one portion of a serving, wait one to two hours, then make an informed decision on whether to consume more. Always dose carefully and listen to your body, and never drive under the influence of cannabis.
Tuesday - Friday from 4:20pm - 5:20pm
Our bud-tenders will select 2 strains that will be on sale for $8.65, along with 100 mg Trichs.
Enjoy some coffee between 9 and 11 a.m. and a pre-roll on Sunday at our San Mateo store.
The House Financial Services subcommittee on Consumer Protection and Financial Institutions held a hearing Wednesday to address the lack of access to basic banking services by state-legal marijuana businesses.
Currently, state-licensed marijuana businesses face a web of conflicting regulations and federal prohibitions largely prohibit these businesses from partnering with financial institutions, processing credit cards, and taking standard business deductions.
NORML Deputy Director Paul Armentano submitted written congressional testimony, which you can read here.NORML Political Director Justin Strekal published on op-ed on the topic in The Hill Newspaper, entitled Businesses need bank accounts — marijuana shops included.
One of the best ways to speed up marijuana legalization is by allowing the existing companies access to basic banking services and it is encouraging to see Congress begin the conversation.
You can watch the hearing below.
Courtesy of NORML.
Island Sweet Skunk, sometimes called Sweet Island Skunk, is a sativa strain that users enjoy for its energetic effects. The flavor is most easily described as “sweet skunk,” where tropical fruit flavors take the lead. Often the fruity aroma is likened to grapefruit.
Users describe the Purple Haze high as one with almost immediate high-energy cerebral stimulation accompanied by an intense sense of creative inspiration and blissful contentment. You may experience a mild body buzz that is warming and spreads from your head and neck throughout the rest of your body. Due to these potent effects, Purple Haze in ideal strain for treating patients suffering from conditions such as fatigue, mild to moderate cases of depression, and chronic stress or anxiety.
Purple Haze has a sweet earthy berry aroma and a pungent berry taste with a hint of spice.
King Tut the strain is a sativa-dominant hybrid (sativa/indica ratio of 80:20) with an uncertain parentage, though it’s known to descend from the legendary sativa-dominant AK-47. The high is cerebral and peppy, making this a good choice for daytime errands, social events, or creative endeavors. Use this strain to treat depression, chronic pain, stress, inflammation, and nausea. King Tut tastes like fresh fruit and flowers and has a sour, Skunky smell.
Recreational marijuana is one step closer to becoming a reality in our state.
On Saturday, HB 356 advanced in the House Health and Human Services Committee. HB 356 would regulate the use, production and sale of cannabis and cannabis products for those over the age of 21.
"It's time that we end the prohibition of cannabis," said Rep. Javier Martinez, one of the sponsors of the bill.
"This proposed legislation ensures that we lead the way with a legalization framework that protects medical cannabis patients, ensures public safety, and advances social justice for low-income, communities of color."
The bill includes public health and safety provisions, as well as investments in safety and education.
It would potentially create a Community Reinvestment Fund that would be used to fund numerous resources like legal services, medical care, outreach services and education for youth.
The bill now moves to the House Judiciary Committee.
Courtesy of KOB.
Picture this. You are preparing an elegant dinner for yourself and your significant other. You head into a liquor store looking for the perfect alcoholic beverage to complement the flavors of your meal. Do you walk up to the counter and ask the shopkeeper for the bottle with the highest alcohol percentage? Most likely not, as Everclear doesn’t really have the most appetizing taste.
But with the advent of state legal marijuana, many dispensaries in the United States report that medical patients or recreational users tend to do just that when selecting their strains. “Which one has the highest THC content,” is a question often heard by the ears of bud tenders, suggesting that anything with a lower count isn’t worth their dollar. But that couldn’t be further from the truth. After all, what is the reason that sometimes one drinks a beer, another time one enjoys a glass of wine, and yet another night one savors a smooth whiskey on the rocks?
The problem with selecting cannabis strains based solely on the THC content is much like stomaching the worst swill at the bar just because it has a high alcoholic percentage. By doing this, the consumer is robbing themselves of not only the rich scents and flavors of the strain, but also missing out on the beneficial effects that can be delivered through a strain’s specific terpene profile.
Terpenes are essential oils that determine all of these factors and make each strain unique. Together with the cannabinoid content — compounds such THC or CBD — we get what’s often referred to as an “entourage effect,” which ultimately has the final say in what kind of benefits you can receive from a particular strain. In fact, it has almost gotten to the point where one can zero in on what exactly they would like a strain to do for them, and by studying the effects of the individual terpenes, with a little trial-and-error, they can find the perfect strain to suit their needs.
But because of the limited scientific research done inside the United States on marijuana, many of these discoveries have been made “in the field” by the underground cannabis users.
“It’s almost as if the rest of the scientific community is in the present, but as far as marijuana is concerned, we are sitting at the forefront of the scientific revolution,” says Adam Laikin, Director of Marketing for Tryke companies.
Darin Carpenter, Director of Cultivation at Tryke, feels passionately about the science of terpenes. We spoke to him to get a better idea about the fascinating discoveries happening in this space.
Mike Pizzo: When did people really start looking at terpenes as a variable in the cultivation process for marijuana?
Darin Carpenter: I think generally people were looking at terpenes — whether they knew it or not — way back in the underground days, because terpenes are what give the cannabis its smell. Some people prefer very strong, pungent types of smells. Others prefer the sweet types of smells. Other growers didn’t want any type of smell. But it was all based on the concentration and makeup of the terpenes.
More recently, I think, the terpenes became more of a major subject of interest, once states started mandating analytical labs to test the different potencies of various compounds. This caused people to start truly questioning the effects and combinations of terpenes and cannabinoids.
What are some good examples of how the entourage effect works or how cultivators zero in on what is going to work together in a strain?
It’s synergy; multiple elements that work together to amplify an effect. When the cannabinoids are paired with terpenes and certain concentrations of them, that’s what generally provides the particular effect. What science understands now is that the combination of those terpenes actually has the ultimate say in the type of effect and intensity that one experiences when consuming cannabis.
Cannabinoids do have a very specific effect, but the terpenes work to amplify that effect and move it to a more particular subset, whether it’s anti-anxiety, paired with pain remediation, or helping people with insomnia, etc. CBD, for instance, is known to be a neural protectant. So that’s the effect of it, helping people with seizures, etc. When people are consuming a CBD plant with one profile of terpenes, they might get a different effect than consuming a different CBD plant with a different terpene profile.
What are some of the more popular terpenes, or are they well known enough to be popular?
Well, for instance, myrcene gives off the sweet smell, more indicative of indica plants. Then you have limonene, which has more of a citrus odor, which leans heavier into sativas. There are over 200 terpenes out there, it’s just the molecular composition that changes its odor and effect.
I think there is a lot more experimentation that needs to be done. Certain labs are actually increasing the number of terpenes and cannabinoids that they are actually looking for, in an effort to understand the entourage effect of the molecular profile of that particular genetic and how it effects individuals. You can break the terpenes down to a core group, but there might be some other compounds that actually are enhancing that core group for the total enhancement. There is a lot more work that needs to be done.
Probably because there are so many combinations out there, right?
Right. So, for instance, Medusa, some people just don’t like Medusa. It doesn’t work for them. But for me, it might be the thing that takes my pain away. It might be the thing that helps me with anxiety, or symptom I am trying to control. One strain might work for you, that may not work for me the same way. One may make you feel relaxed and comfortable, while I might get a feeling of paranoia.
Everyone is harping on, “I have to have the highest THC concentration.” To me, it’s not about that. It’s the effect and finding the strain that works for you, particularly. Yes, THC gives you that psychoactive effect, but some of the better strains out there aren’t higher THC. It’s the combination of the flavors and the terpenes that are paired with the THC and the cannabinoids that make it so powerful. People see THC as a value proposition, like “I am spending $25 an eighth and this one’s got 30% THC. Why would I spend $35 or $45 on something that’s got 15%?” If they tried it, they might see that it’s not all the THC. They actually might get a better effect, taste and experience because of the terpene/cannabinoid profile that works best for them.
Federal law has made it really difficult to study cannabis in the United States, so there is not a lot of scientific research done on this here, right?
Yeah, not a lot in the United States. Israel and England is where most of the research is being done.
That actually brings up another point, that a lot of the “testing” is going on in the field, where people are going “This worked for me, this didn’t,” etc. And through word-of-mouth, those findings are kind of going “viral” in the cannabis community, is that right?
Yeah. A lot of the guys in Mendocino and Santa Rosa, the Emerald Triangle area, they were kind of growing and breeding what works for them and what speaks to them. That’s really kind of how it’s been, but nobody that I am aware of has really started a targeted breeding program to develop strains to create a library with a wide range of particular effects, quality and yield.
So do you think people that are purchasing based only on a super high THC levels are doing so out of naivety?
It’s not always about the concentration of the psychoactive ingredients in the flower. It is the combination of the terpenes and cannabinoids that provide that effect. So if people are looking for something, they don’t need to go for that super high-potency strain. Yes, it may work for them, but there are other options that may or may not.
For me, I hate expensive beers. If you take some super craft, micro brew with a heavy amount of hops and for me it just tastes too bitter. It doesn’t quench my thirst. I prefer other types of flavors when enjoying a beer. I think when educating the patients, we need to explain that you will still get the desired effect in most cases, and because of that, you should enjoy something that has the flavor profile smell and look that speaks to you and controls their individual symptoms.
The overuse and misuse of opioid medications is major public health problem for which we don’t currently have an effective solution. Nearly 2.5 million Americans struggle with opioid addiction and over 100 people die every day from opioid overdose. Though controversial, more and more evidence is showing that medical cannabis could be a lifesaving component of a strategy to solve to this epidemic.
I recently had the opportunity to work with Sanjay Gupta on the fourth installment of his groundbreaking series on CNN, Weed 4: Pot vs. Pills, which aired last month, helping to explain how cannabis can be a solution to this epidemic.
Thousands of people have used cannabis to help them reduce and replace opioid medications, as demonstrated in numerous recent scientific papers and strongly supported by animal research.Like the reports in the scientific literature, I’ve seen the same positive results firsthand in my medical practices. From a survey of our patients in 2016, of the 542 opioid users who added cannabis:
Cannabis alone isn’t enough to completely solve this epidemic, but we know it can help replace the opioids, improve their safety, and increase adherence to addiction treatment programs.
It’s essential that everyone who is concerned with this problem learn about the potential solution that’s right within reach, so we can make this life-saving treatment available for those dependent on opioids. For this reason, I have created guidelines based on my experience treating chronic pain with cannabis in 8 years of clinical practice, conferring with my colleagues, and closely following the scientific literature. These guidelines apply to patients from any walk of life, including those with chronic pain, PTSD, addiction, non-medical use of opioids, etc.
In How to Use Cannabis to Reduce and Replace Opioid Medications, you’ll find the advantages of adding cannabis, complete with scientific references and specific dosing strategies for successfully relieving the symptoms of opioid withdrawal and enhancing the safety and medical benefits of opioids.The guide includes links to several of my free online cannabis education programs for both patients new to cannabis and experienced cannabis consumers, and other programs that can help improve your likelihood of successfully using cannabis to reduce and replace opioid medications.
This guide is provided as an information resource only, and is not to be used or relied on for diagnostic or treatment purposes. It is not intended to be patient education, does not create any patient-physician relationship, and should not be used as a substitute for professional diagnosis and treatment. I strongly suggest that patients:
Those who are most successful in using cannabis to replace opioid drugs always use a combination of pharmacologic and behavioral interventions. No medication is powerful enough to accomplish this goal on its own. By prioritizing and organizing the proper resources for sleep, exercise, counseling, support groups, and social support, you can ensure your success.If you decide to follow this path of treatment to reduce or replace medications, I want to learn from your experiences. Please share them with me here.https://www.leafly.com/news/health/using-cannabis-to-reduce-opioid-dependence
Pain is the number one reason people seek medical care—and quite possibly medical cannabis—and it affects more people than diabetes, heart disease, and cancer combined. In the clinic, pain is often treated with opioid drugs like OxyContin, Percocet, Vicodin, and Fentanyl. This has traditionally been a first-line treatment approach because they work—at first.
But opioid use has spiraled out of control and we find ourselves amidst an opioid epidemic that cost the U.S. $504 billion in 2015 alone, claims the lives of over 30,000 annually, and damages the quality of life of countless others. Clearly, we must do something to curb the growing opioid epidemic, but unfortunately, it appears that the federal government is ignoring one of its strongest solutions: cannabis.
We know that cannabis is effective in treating chronic pain. We understand its ability to effectively substitute for opioid medication, and that CBD can combat opioid abuse by reducing its rewarding effects. Here, we’ll take a look at how cannabis enhances the effects of opioids—an interaction worth exploring in an era plagued by opioid dependence and overdose.
The original natural painkiller, opium, dates back to 3,400 B.C. in Southwestern Asia. Cannabis followed a half a century later. It’s unclear if they were ever used together to treat pain, but consumers would have found profound pain relief from low doses of both drugs when used together.Science is revealing that the cannabinoid and opioid systems can work synergistically to achieve greater pain relief. This interaction becomes clear when you consume super low-doses of THC or opioids; on their own, these low doses do not relieve pain, but in combination, they do.
For instance, a recent double-blinded, placebo-controlled study (the gold-standard in clinical research) investigated the effects of low-dose cannabis (5.6% THC) and the opioid drug, oxycodone (2.5 mg) on pain thresholds in human subjects. Neither THC nor oxycodone independently affected pain, but when used in combination, participants were able to withstand higher levels of painful stimuli consistent with substantial pain reductions.To achieve these pain-relieving effects, could THC’s primary target, cannabinoid type I (CB1) receptors, and opioid receptors be working together? There’s evidence that they do.Take mice that have been genetically engineered to not express CB1 receptors (that’s right, you can create mice without CB1 receptors!). These mice enjoy nicotine, amphetamines, cocaine, and they’ll eagerly press a lever to self-administer these drugs. But they won’t do it for the opioid drug, heroin. Normal mice do, but not the mice without CB1 receptors. This tells us that CB1 receptors are important in the euphoric effects of heroin. Extending these findings to pain, blocking the activity of CB1 receptors weakensmorphine’s ability to reduce pain.
So CB1 receptors are important in opioid drugs’ ability to make you feel good and reduce pain.These are two critical elements driving the opioid epidemic and an integral component of the pain experience. After all, pain is subjective. The severity of pain is determined by numerous factors including:
Opioid medications predominately target two of these factors. First, they weaken the strength of the pain signals from the site of injury to your brain, and second, they improve your mood by boosting levels of the pleasurable dopamine chemical.
These dual effects make stopping opioid use difficult, especially when repeated opioid use leads to long-term brain changes that reduce the number of opioid receptors in the brain and body. Lower numbers of opioid receptors enable stronger pain signals to enter your brain and reduces the levels of mood-boosting dopamine. This is the phenomenon of tolerance, which leads to increased opioid consumption, the transition to stronger drugs, and increased risk for overdose and death.
Pain signals begin at the site of injury, then make their way into the spinal cord and travel up to the brain. After exiting the spinal cord, they activate brain cells in critical pain processing regions including the periaqueductal gray, thalamus, and cortex. If you were to design a pain medication, you’d try to (a) weaken pain signals as they enter and exit the spinal cord and (b) dampen their effect in the brain.CB1 receptors and opioid receptors, specifically the µ-opioid receptors that modulate pain, are found expressed together in the spinal cord, the periaqueductal gray, and the brain’s reward centers. That is, you find these two receptors together in all the places that are important in pain relief.
Once activated by either opioids or cannabinoids, they share many common downstream signaling features. In fact, if you activate one receptor, it affects how the other one responds. This has led many to believe that the CB1 and µ-opioid receptors physically interact. The consequence of this interaction depends on where in the brain they’re found, but in some cases, it means that their co-activation by low amounts of drug leads to a stronger effect than what would be predicted by activating either CB1 or opioid receptors on their own.While the physical interaction between CB1 and opioid receptors is likely important for the pain-relieving effects of cannabis and opioids, cannabis can enhance the effect of opioids by also increasing the body’s endogenous opioid levels, themselves. The effect is reciprocal; THC can increase opioid levels to help relieve pain, and using drugs to boost the body’s own opioid levels enhances THC’s pain-relieving effects.
So, taken together, cannabis can increase opioid’s pain-relieving effects by modulating opioid-receptor signaling directly through physical interaction between CB1 and opioid receptors, and by increasing the body’s own opioid levels.
THC’s other primary target, the CB2 receptor, can also interact with the opioid system but these effects are less well-studied. The greatest evidence for CB2’s effects on opioid signaling occurs at the site of injury, where activating CB2 receptors stimulates the release of endogenous opioids to help dampen the pain where it starts. As discussed in part one of this series, CB2 receptors play a large role in regulating inflammation.https://www.leafly.com/news/health/how-opioids-marijuana-work-together-for-pain-relief
SANTA FE, N.M. (KRQE) - For the first time this session, lawmakers are taking a stab at legalizing recreational marijuana in the state.The bill, sponsored by House Democrats, would make it legal for anyone 21 and over to possess up to two ounces of pot.It also provides for a person to grow up to six mature plants in their home.
The law would allow towns and cities to ban the sale of pot, but they could not ban the use or growing of marijuana in private homes.The bill will have to clear two House communities to be heard on the House floor.
Courtesy of KRQE.